Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

Nevro had a negative return on equity of 23.52% and a negative net margin of 16.54%. On average, equities research analysts forecast that Nevro will post -2.44 earnings per share for the current year.

Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced Modulus ...

After hours: March 14 at 6:00:01 p.m. EDT Loading Chart for NVRO ...

After hours: March 13 at 5:21:55 p.m. EDT ...

Globus Medical, Inc. reported $657,293 million in sales and $60,275 million in operating profit for the quarter ending December 31, 2024, which was above both Wall Street’s expectations and management ...